Michelle L Varney1, Rakesh K Singh1. 1. Department of Pathology and Microbiology, The University of Nebraska Medical Center, 985900 Nebraska Medical Center Omaha, NE 68198-5900.
Abstract
PURPOSE: Lymphangiogenic factors, such as vascular endothelial growth factor-C (VEGF-C) and VEGFC-D, and their receptor, VEGF receptor-3 (VEGFR3), play a pivotal role in the promotion of metastasis to regional lymph nodes. In the present study we explored the role of VEGF-C as an autocrine growth factor for breast cancer cells. METHODS: We examined the expression of VEGF-C and VEGFR3 in mammary tumor cells lines and examined whether blocking the VEGF-C-VEGFR3/Flt4 pathway using a VEGFR3 antagonist would inhibit proliferation of mammary tumor cells resulting in a decrease in tumor growth and metastasis. RESULTS: We report expression of VEGF-C and its receptor VEGFR3 by mammary tumor cells, and their association with aggressiveness. Inhibition of VEGF-C-VEGFR3/Flt4 in mammary tumor cells decreased their proliferation and survival. Mammary tumor bearing mice treated with a VEGFR3 antagonist showed a significant decrease in tumor growth and the extent of spontaneous and experimental lung metastases. CONCLUSION: These findings demonstrate the VEGF-C-VEGFR3/Flt4 autocrine signaling pathway regulates mammary tumor cell survival and proliferation and that neutralization of VEGFR3 signaling might lead to development of a novel therapeutic approach for malignant breast cancer.
PURPOSE: Lymphangiogenic factors, such as vascular endothelial growth factor-C (VEGF-C) and VEGFC-D, and their receptor, VEGF receptor-3 (VEGFR3), play a pivotal role in the promotion of metastasis to regional lymph nodes. In the present study we explored the role of VEGF-C as an autocrine growth factor for breast cancer cells. METHODS: We examined the expression of VEGF-C and VEGFR3 in mammary tumor cells lines and examined whether blocking the VEGF-C-VEGFR3/Flt4 pathway using a VEGFR3 antagonist would inhibit proliferation of mammary tumor cells resulting in a decrease in tumor growth and metastasis. RESULTS: We report expression of VEGF-C and its receptor VEGFR3 by mammary tumor cells, and their association with aggressiveness. Inhibition of VEGF-C-VEGFR3/Flt4 in mammary tumor cells decreased their proliferation and survival. Mammary tumor bearing mice treated with a VEGFR3 antagonist showed a significant decrease in tumor growth and the extent of spontaneous and experimental lung metastases. CONCLUSION: These findings demonstrate the VEGF-C-VEGFR3/Flt4 autocrine signaling pathway regulates mammary tumor cell survival and proliferation and that neutralization of VEGFR3 signaling might lead to development of a novel therapeutic approach for malignant breast cancer.
Authors: Vladimir Kirkin; Wilko Thiele; Petra Baumann; Ralph Mazitschek; Katrin Rohde; Guido Fellbrich; Herbert Weich; Johannes Waltenberger; Athanassios Giannis; Jonathan P Sleeman Journal: Int J Cancer Date: 2004-12-20 Impact factor: 7.396
Authors: Zhengtang Chen; Michelle L Varney; Matthew W Backora; Kenneth Cowan; Joyce C Solheim; James E Talmadge; Rakesh K Singh Journal: Cancer Res Date: 2005-10-01 Impact factor: 12.701
Authors: Marissa J Stanton; Samikshan Dutta; Heyu Zhang; Navatha S Polavaram; Alexey A Leontovich; Pia Hönscheid; Frank A Sinicrope; Donald J Tindall; Michael H Muders; Kaustubh Datta Journal: Cancer Res Date: 2012-11-13 Impact factor: 12.701
Authors: Elena V Kurenova; Darrell L Hunt; Dihua He; Ann D Fu; Nicole A Massoll; Vita M Golubovskaya; Christopher A Garces; William G Cance Journal: Cell Cycle Date: 2009-07-23 Impact factor: 4.534
Authors: Leya Groysman; Lindsey Carlsen; Kelsey E Huntington; Wen H Shen; Lanlan Zhou; Wafik S El-Deiry Journal: Am J Cancer Res Date: 2021-12-15 Impact factor: 6.166
Authors: R M Kershaw; D Roberts; J Wragg; A M Shaaban; E Humphreys; J Halsall; L Price; R Bicknell; K Gaston; P-S Jayaraman Journal: Oncogenesis Date: 2017-06-12 Impact factor: 7.485
Authors: Zhiwei Liu; Troy J Kemp; Yu-Tang Gao; Amanda Corbel; Emma E McGee; Juan Carlos Roa; Bingsheng Wang; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto; Jill Koshiol Journal: Sci Rep Date: 2018-04-04 Impact factor: 4.379